MYGN:NASDAQ
Myriad Genetics Inc
4,30 $
arrow_downward
-0,35%(-0,015) 1D
12 қаз., 10:04:18 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for MYGN...
Open
4,30 $
High
4,32 $
Low
4,27 $
Mkt. cap
409,38 млн
Avg. vol.
2,04 млн
Volume
19,52 мың
52-wk high
8,59 $
52-wk low
2,74 $
EPS
-1,20 $
Beta
1,64
Shares outstanding
95,65 млн
No. of employees
3 мың
Open
4,30 $
High
4,32 $
Low
4,27 $
Mkt. cap
409,38 млн
Avg. vol.
2,04 млн
Volume
19,52 мың
52-wk high
8,59 $
52-wk low
2,74 $
EPS
-1,20 $
Beta
1,64
Shares outstanding
95,65 млн
No. of employees
3 мың
News stories
From web sources and news partners
Yahoo Finance
·
29 минут бұрын
A handful of tech stocks are masking an ugly S&P 500 problem
GlobeNewswire
·
35 минут бұрын
Stewards Inc. to Ring Nasdaq Opening Bell on Oct. 14, Celebrating Company's Next Chapter
PR Newswire
·
35 минут бұрын
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Kymera Therapeutics, Inc. (NASDAQ: KYMR)
Kansas City Star
·
25 минут бұрын
Wall St steady at open as oil jumps ahead of key earnings
Profile
Myriad Genetics, Inc. is an American genetic testing and precision medicine company based in Salt Lake City, Utah, United States. Myriad employs a number of proprietary technologies that permit doctors and patients to understand the genetic basis of human disease and the role that genes play in the onset, progression and treatment of disease. This information is used to guide the development of new products that assess an individual's risk for developing disease later in life, identify a patient's likelihood of responding to a particular drug therapy, assess a patient's risk of disease progression and disease recurrence, and measure disease activity. Wikipedia
About Myriad Genetics Inc
CEOPaul J. Diaz | Paul J. Diaz
Employees2,7 мың
Founded1991
HeadquartersСолт-Лейк қаласы, Юта, Америка Құрама Штаттары
Sector-
Websitemyriad.com